GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » LT-Debt-to-Total-Asset

Baijin Life Science Holdings (HKSE:01466) LT-Debt-to-Total-Asset : 0.22 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Baijin Life Science Holdings's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.22.

Baijin Life Science Holdings's long-term debt to total assets ratio increased from Sep. 2023 (0.00) to Sep. 2024 (0.22). It may suggest that Baijin Life Science Holdings is progressively becoming more dependent on debt to grow their business.


Baijin Life Science Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Baijin Life Science Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings LT-Debt-to-Total-Asset Chart

Baijin Life Science Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 - 0.01 - 0.21

Baijin Life Science Holdings Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.21 0.22

Baijin Life Science Holdings LT-Debt-to-Total-Asset Calculation

Baijin Life Science Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=40.66/196.802
=0.21

Baijin Life Science Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=52.995/236.695
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baijin Life Science Holdings  (HKSE:01466) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Baijin Life Science Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Baijin Life Science Holdings Business Description

Traded in Other Exchanges
Address
110-116 Queen’s Road Central, Room 906, 9th Floor, Wings Building, Central, Hong Kong, HKG
Affluent Partners Holdings Ltd is an investment holding company with subsidiaries engaged in purchasing, processing, designing, production, and wholesale distribution of pearls and jewelry products and operation of strategic investment and financial services. Its operating segment includes the Sale of pearls and jewelry products, Strategic investment and financial services, Skincare solutions business segment, Research and development services segment, and Brand marketing and consulting services segment It generates maximum revenue from the Sale of pearls and jewelry products segment. It operates geographically in Hong Kong, the PRC, the USA, the UK, and Europe. It generates the majority of its revenue from the USA.
Executives
Su Yaoyao 2201 Interest of corporation controlled by you
Pacific Wish Limited
Ketto Inform Limited 2101 Beneficial owner
Chan Vincent Wing Sing
Hui Ka Man Emily

Baijin Life Science Holdings Headlines

No Headlines